-transparent.png){kind=logo}
Cardiovascular disease has become the major cause of death in the Western countries. There is strong evidence that elevations of serum lipids contribute to the pathogenesis of premature atherosclerosis. The classification of the hyperlipoproteinemias has been most beneficial as a guide to development of dietary and pharmacological regimens for lowering serum lipid concentrations. The results of dietary and drug prevention trials are discussed. Insight into the mechanisms involved in lipoprotein metabolism as well as the mode of action and of side-effects of hypolipidemic drugs is reviewed. Using present knowledge of heart disease research, it is reasonable to suggest dietary and drug treatments for the high risk patient.
G Klose, and
R Mordasini, and
G Middelhoff, and
J Augustin, and
H Greten
April 1981,
Anales espanoles de pediatria,
G Klose, and
R Mordasini, and
G Middelhoff, and
J Augustin, and
H Greten
November 1980,
Therapeutische Umschau. Revue therapeutique,
G Klose, and
R Mordasini, and
G Middelhoff, and
J Augustin, and
H Greten
June 1980,
Tijdschrift voor diergeneeskunde,
G Klose, and
R Mordasini, and
G Middelhoff, and
J Augustin, and
H Greten
March 1974,
Deutsche medizinische Wochenschrift (1946),
G Klose, and
R Mordasini, and
G Middelhoff, and
J Augustin, and
H Greten
January 1979,
Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten,
G Klose, and
R Mordasini, and
G Middelhoff, and
J Augustin, and
H Greten
October 1977,
Monatsschrift fur Kinderheilkunde,
G Klose, and
R Mordasini, and
G Middelhoff, and
J Augustin, and
H Greten
August 1972,
Annals of internal medicine,
G Klose, and
R Mordasini, and
G Middelhoff, and
J Augustin, and
H Greten
August 1976,
Leber, Magen, Darm,
G Klose, and
R Mordasini, and
G Middelhoff, and
J Augustin, and
H Greten
November 1980,
Therapeutische Umschau. Revue therapeutique,
G Klose, and
R Mordasini, and
G Middelhoff, and
J Augustin, and
H Greten
March 1978,
Klinische Wochenschrift,
